Effect of High-Risk Human Papillomavirus but Normal Cytology at Test of Cure on Achieving Colposcopy Standards

Emmanouil Kalampokas, Judith Wilson, Mahalakshmi Gurumurthy, Margaret E. Cruickshank

Research output: Contribution to journalArticle

1 Citation (Scopus)
5 Downloads (Pure)

Abstract

Objective: In U.K., Test of Cure (ToC) after treatment of any grade of CIN incorporates high risk-HPV (Hr-HPV) test and cytology at 6 months follow-up. Our aim was to determine the rate of recurrent Cervical Intraepithelial Neoplasia (CIN) in women who are Hr-HPV positive and cytology negative and explore possible associated risk factors.

Methods: A retrospective observational cohort study was performed of women treated for any grade CIN between 2010-2015 from a regional population who were Hr-HPV positive and cytology negative at first follow-up.

Results: 2729 women were identified as treated for any grade CIN and 213 (7.8%) were re-referred to colposcopy having Hr-HPV positive test and negative cytology at ToC. Their mean age was 31.56 years (range 19-62 years). The mean time of follow-up per woman was 30.50 months (2-63 months). At colposcopy, 171 (80.3%) had colposcopy examination only and 42 (19.7%) women had a biopsy. 24 (11.3%) cases of CIN were identified of which 4 (1.9%) were CIN2/3. 11 (5.2%) women in total had a repeat treatment. 5 (2.3%) women had biopsy proven CIN2/3 within 12 months post-treatment. No cases of CIN3+ after negative colposcopy were identified during the follow-up period.

Conclusions: The incorporation of Hr-HPV testing yielded a very small number of women with residual CIN within 12 months of treatment. Our results suggest that women who are Hr-HPV positive and cytology negative post-treatment of CIN with normal adequate colposcopy could be discharged to routine recall if confirmed by larger national data.
Original languageEnglish
Pages (from-to)110-114
Number of pages5
JournalJournal of Lower Genital Tract Disease
Volume22
Issue number2
Early online date23 Feb 2018
DOIs
Publication statusPublished - 1 Apr 2018

Fingerprint

Colposcopy
Cervical Intraepithelial Neoplasia
Cell Biology
Biopsy
Therapeutics
Observational Studies
Cohort Studies

Keywords

  • Test of cure
  • HPV positive
  • cytology negative
  • follow-up

Cite this

Effect of High-Risk Human Papillomavirus but Normal Cytology at Test of Cure on Achieving Colposcopy Standards. / Kalampokas, Emmanouil; Wilson, Judith; Gurumurthy, Mahalakshmi; Cruickshank, Margaret E.

In: Journal of Lower Genital Tract Disease, Vol. 22, No. 2, 01.04.2018, p. 110-114.

Research output: Contribution to journalArticle

@article{fad60fff77754f41b11b4e8f5c298ffe,
title = "Effect of High-Risk Human Papillomavirus but Normal Cytology at Test of Cure on Achieving Colposcopy Standards",
abstract = "Objective: In U.K., Test of Cure (ToC) after treatment of any grade of CIN incorporates high risk-HPV (Hr-HPV) test and cytology at 6 months follow-up. Our aim was to determine the rate of recurrent Cervical Intraepithelial Neoplasia (CIN) in women who are Hr-HPV positive and cytology negative and explore possible associated risk factors.Methods: A retrospective observational cohort study was performed of women treated for any grade CIN between 2010-2015 from a regional population who were Hr-HPV positive and cytology negative at first follow-up.Results: 2729 women were identified as treated for any grade CIN and 213 (7.8{\%}) were re-referred to colposcopy having Hr-HPV positive test and negative cytology at ToC. Their mean age was 31.56 years (range 19-62 years). The mean time of follow-up per woman was 30.50 months (2-63 months). At colposcopy, 171 (80.3{\%}) had colposcopy examination only and 42 (19.7{\%}) women had a biopsy. 24 (11.3{\%}) cases of CIN were identified of which 4 (1.9{\%}) were CIN2/3. 11 (5.2{\%}) women in total had a repeat treatment. 5 (2.3{\%}) women had biopsy proven CIN2/3 within 12 months post-treatment. No cases of CIN3+ after negative colposcopy were identified during the follow-up period.Conclusions: The incorporation of Hr-HPV testing yielded a very small number of women with residual CIN within 12 months of treatment. Our results suggest that women who are Hr-HPV positive and cytology negative post-treatment of CIN with normal adequate colposcopy could be discharged to routine recall if confirmed by larger national data.",
keywords = "Test of cure, HPV positive, cytology negative, follow-up",
author = "Emmanouil Kalampokas and Judith Wilson and Mahalakshmi Gurumurthy and Cruickshank, {Margaret E.}",
note = "Acknowledgements: We thank Sister Christine Godley for helping with data collection. Declaration of Interests: The authors have no conflicts of interest to declare. Funding: None.",
year = "2018",
month = "4",
day = "1",
doi = "10.1097/LGT.0000000000000373",
language = "English",
volume = "22",
pages = "110--114",
journal = "Journal of Lower Genital Tract Disease",
issn = "1089-2591",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Effect of High-Risk Human Papillomavirus but Normal Cytology at Test of Cure on Achieving Colposcopy Standards

AU - Kalampokas, Emmanouil

AU - Wilson, Judith

AU - Gurumurthy, Mahalakshmi

AU - Cruickshank, Margaret E.

N1 - Acknowledgements: We thank Sister Christine Godley for helping with data collection. Declaration of Interests: The authors have no conflicts of interest to declare. Funding: None.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Objective: In U.K., Test of Cure (ToC) after treatment of any grade of CIN incorporates high risk-HPV (Hr-HPV) test and cytology at 6 months follow-up. Our aim was to determine the rate of recurrent Cervical Intraepithelial Neoplasia (CIN) in women who are Hr-HPV positive and cytology negative and explore possible associated risk factors.Methods: A retrospective observational cohort study was performed of women treated for any grade CIN between 2010-2015 from a regional population who were Hr-HPV positive and cytology negative at first follow-up.Results: 2729 women were identified as treated for any grade CIN and 213 (7.8%) were re-referred to colposcopy having Hr-HPV positive test and negative cytology at ToC. Their mean age was 31.56 years (range 19-62 years). The mean time of follow-up per woman was 30.50 months (2-63 months). At colposcopy, 171 (80.3%) had colposcopy examination only and 42 (19.7%) women had a biopsy. 24 (11.3%) cases of CIN were identified of which 4 (1.9%) were CIN2/3. 11 (5.2%) women in total had a repeat treatment. 5 (2.3%) women had biopsy proven CIN2/3 within 12 months post-treatment. No cases of CIN3+ after negative colposcopy were identified during the follow-up period.Conclusions: The incorporation of Hr-HPV testing yielded a very small number of women with residual CIN within 12 months of treatment. Our results suggest that women who are Hr-HPV positive and cytology negative post-treatment of CIN with normal adequate colposcopy could be discharged to routine recall if confirmed by larger national data.

AB - Objective: In U.K., Test of Cure (ToC) after treatment of any grade of CIN incorporates high risk-HPV (Hr-HPV) test and cytology at 6 months follow-up. Our aim was to determine the rate of recurrent Cervical Intraepithelial Neoplasia (CIN) in women who are Hr-HPV positive and cytology negative and explore possible associated risk factors.Methods: A retrospective observational cohort study was performed of women treated for any grade CIN between 2010-2015 from a regional population who were Hr-HPV positive and cytology negative at first follow-up.Results: 2729 women were identified as treated for any grade CIN and 213 (7.8%) were re-referred to colposcopy having Hr-HPV positive test and negative cytology at ToC. Their mean age was 31.56 years (range 19-62 years). The mean time of follow-up per woman was 30.50 months (2-63 months). At colposcopy, 171 (80.3%) had colposcopy examination only and 42 (19.7%) women had a biopsy. 24 (11.3%) cases of CIN were identified of which 4 (1.9%) were CIN2/3. 11 (5.2%) women in total had a repeat treatment. 5 (2.3%) women had biopsy proven CIN2/3 within 12 months post-treatment. No cases of CIN3+ after negative colposcopy were identified during the follow-up period.Conclusions: The incorporation of Hr-HPV testing yielded a very small number of women with residual CIN within 12 months of treatment. Our results suggest that women who are Hr-HPV positive and cytology negative post-treatment of CIN with normal adequate colposcopy could be discharged to routine recall if confirmed by larger national data.

KW - Test of cure

KW - HPV positive

KW - cytology negative

KW - follow-up

U2 - 10.1097/LGT.0000000000000373

DO - 10.1097/LGT.0000000000000373

M3 - Article

VL - 22

SP - 110

EP - 114

JO - Journal of Lower Genital Tract Disease

JF - Journal of Lower Genital Tract Disease

SN - 1089-2591

IS - 2

ER -